- Belgian Week of Gastroenterology 2019: BGDO Session - Hilton Antwerp - 22 Feb. 2019 - Go to details
- BGDO Masterclass 2019: Digestive Oncology Course - Secret venue - 26-27 April 2019 - Go to details
- BGDO Annual Meeting 2019: Curative approach in oesophageal cancer and peritoneal carcinomatosis in 2019 - Crowne Plaza Burussels Airport - 12 January 2019 - Go to details
- BGDO Annual Meeting: Adjuvant therapy: today & tomorrow - Crowne Plaza Brussels Airport - 13 JAN 2018 - Go to details
- Belgian Week of Gastroenterology 2018: BGDO Session - Hilton Antwerp - 22 Feb. 2018 - Go to details
Belgian Week of Gastroenterology 2019
BGDO Masterclass 2019
Digestive Oncology Course
Save the date!
The BGDO is organising a third Masterclass on Friday 26 April afternoon and Saturday 27 April all day.
BGDO Annual Meeting 2019
Curative approach in oesophageal cancer and peritoneal carcinomatosis in 2019
BGDO Annual Meeting
Adjuvant therapy: today & tomorrow
The meeting will explore original and interesting topics on ADJUVANT THERAPY: TODAY & TOMORROW.
First, we will start with the General Assembly. A good opportunity to have short glimpse on the new website, the achieved goals, the new collaboration with the FFCD and an update on the ongoing and upcoming trials.
Two highly up-to-date talks will open the Innovation in Oncology session:
- Prof Laurent-Puig addresses the value of Liquid Biopsy in GI cancers, a very hot topic in the near future!
- Another underused practice to improve survival is to follow patient care through Patient-Reported Outcomes (PRO). Prof Marc Peeterswill comment the engaging results that can be obtained by interacting with patients more closely.
This year has been marked by several important trials in the adjuvant setting:
- The IDEA consortium looked at the role of the length of adjuvant chemotherapy in colorectal cancer. Prof Timothy Iveson led the SCOT trial with very interesting results in this setting and will give us the privilege to listen to his analysis.
- In gastric cancer, the FLOT trial sets a new standard in perioperative care, which will be presented by Prof Alain Hendlisz.
- Prof Chris Verslype will discuss the value of capecitabine in hard-to-treat pancreatic and biliary tract cancers.
Last but not least Prof Marc Buyse, world-renowned statistician in the field of oncology, will propose new ways to address clinical trial design, benefit assessment and futuristic statistical methods.
A huge thank you to all our Sponsors, Majors and Regulars.